Lifestyle
- regular exercise
- adequate hydration
- stress management
Platelets · PLT · Blutplättchen
Platelet count measures the number of platelets in the blood, which are essential for blood clotting.
Reference ranges can vary slightly between laboratories.
Platelets, also known as thrombocytes, are small, disc-shaped cell fragments in the blood that are crucial for normal blood clotting. They are produced in the bone marrow and circulate in the bloodstream, where they play a key role in hemostasis by aggregating at sites of vascular injury to form a clot and stop bleeding. Researchers have found that immature platelets, or reticulated platelets, are larger and contain more RNA, indicating recent release from the bone marrow. Clinically, platelet count is an important marker for diagnosing and monitoring various conditions. Elevated platelet counts, or thrombocytosis, can indicate conditions such as inflammation, infection, or myeloproliferative disorders, while low counts, or thrombocytopenia, can suggest bone marrow disorders, increased platelet destruction, or drug-induced effects. For athletes and biohackers, maintaining optimal platelet levels is essential for efficient recovery and minimizing injury risk. Platelet levels can be influenced by factors such as hydration status, exercise intensity, and nutritional intake. Researchers have observed that platelet counts can vary based on time of day and fasting status, with potential confounders including recent exercise and certain medications. Accurate measurement and interpretation of platelet levels require consideration of these factors to avoid misdiagnosis or inappropriate treatment.
Klinische Bedeutung
Elevated platelet counts can indicate inflammation, infection, or myeloproliferative disorders. Reduced platelet counts may suggest bone marrow disorders, increased destruction, or drug-induced thrombocytopenia.
Progressively rising platelet counts may suggest chronic inflammation or myeloproliferative disorders. Retesting in 4 weeks is recommended if outside the optimal range.
Progressively falling platelet counts may indicate bone marrow suppression or increased destruction.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a physician before starting any supplementation, especially if underlying health conditions exist.
Platelet counts may vary slightly throughout the day; consistent timing is recommended.
Testing Frequency
Annually for healthy adults, more frequently if monitoring a specific condition.
Current research suggests that reference ranges and optimal targets for reticulated and immature platelets in various clinical conditions, such as immune-mediated thrombocytopenia and multisystem inflammatory syndrome in children, remain inadequately defined. Researchers have not yet established the full clinical utility of these biomarkers across diverse patient populations, particularly in distinguishing between hypoproduction and accelerated destruction of platelets. Unanswered clinical questions include the role of these immature platelets in real-time monitoring of bone marrow responses to different disease states.
756
Total Citations
18
Human/RCT
2.4
Avg. Influence
2025
Latest
This study summarized the characteristics and functions of procoagulant platelets, a specific subpopulation involved in coagulation. Researchers proposed a unified term for these platelets and discussed their potential as biomarkers for thrombotic events. The findings suggest new therapeutic targets for managing thrombosis.
Researchers conducted a systematic review on the effects of platelet storage duration on clinical outcomes. The findings indicated no significant association between storage time and adverse outcomes in critically ill or hematology patients, although fresher platelets showed better corrected count increments.
Researchers explored the role of platelets in venous thromboembolism (VTE) and their potential as risk factors. The study highlighted the need for further investigation into platelet involvement in VTE and the possible benefits of antiplatelet therapy in prevention. This area shows promise for future research.
Researchers examined the role of platelet microparticle-associated microRNAs in hemostasis and disease. The study suggests that these microparticles may influence intercellular signaling and have diagnostic and therapeutic potential in conditions like cardiovascular diseases and cancer, warranting further investigation.
This review analyzed the clinical applications of reticulated platelets and the limitations of current measurement methods. Researchers found that these immature platelets can provide insights into various health conditions, but emphasized the need for standardized measurement techniques to improve diagnostic accuracy.
Researchers found that reticulated platelets (RPs) are immature platelets that can indicate bone marrow activity and help assess conditions like thrombocytopenia. The study suggests RPs may be useful in differentiating between causes of low platelet counts and predicting recovery after treatments like chemotherapy. Further research is needed to clarify their role in various clinical scenarios.
This study explored the role of platelet membrane glycoproteins in hemostasis. Researchers found that these glycoproteins are crucial for platelet adhesion and aggregation, and their dysfunction can contribute to thrombotic disorders.
This study examined the role of procoagulant platelets in blood clot formation and their clinical significance. Researchers found that reduced levels are linked to bleeding disorders, while elevated levels are associated with thrombotic conditions, such as increased stroke risk. The study highlights the need for standardized assays to measure procoagulant platelets for better clinical management.
Researchers explored the interactions between platelets and pancreatic cancer, highlighting their role in tumor progression. They found that pancreatic tumors can enhance platelet aggregation, contributing to thrombosis. The study suggests that understanding this crosstalk may lead to new diagnostic and therapeutic strategies for pancreatic cancer.
This study examined the role of immature platelets in diagnosing immune-mediated thrombocytopenia. Researchers observed that measuring immature platelet counts can provide insights into bone marrow responses during thrombocytopenia. The findings suggest that immature platelets may help differentiate between various causes of low platelet counts.
Research publications about Thrombozyten over time
8totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer